- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02115971
Jumping Exercises Approach in Individuals With Chronic Ankle Instability
The Effect of a 12-week Training Jumping Exercises Program in Individuals With Chronic Ankle Instability: Randomized Controlled Trial Pilot Study
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
There is a need for;
- more homogeneous sub- groups with chronic functional instability of the ankle.
- Studies are needed that older patients (up to 50 years) and also take into account women.
- In addition, studies should be performed in a clinical environment and also at the same time clinically adapted test can be used as a form measurement.
( Hiller et al. , 2011).
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
ZH
-
Zurich, ZH, Svizzera, 8008
- Balgrist Univeresty Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Ankle injury more than 6 months ago
- Chronic instability
- Functional instability of the ankle
- Experience with proprioceptive exercises
Exclusion Criteria:
- Foot surgery
- Fresh ankle injury
- Acute foot pain with signs of inflammation
- Mechanical / anatomical ankle instability
- Athletes with regularly jumping exercise (eg volleyball, basketball)
- Taking medications which affect balance and coordination
- Diseases that affect the balance
- Serious diseases such as tumors, infections, neuropathies, severe articular degeneration
- Non-German-speaking patients
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Jumping exercise
Physical therapy with a focus on specific jumping exercise. The jumping exercise will be performed for 12 weeks (3x/week), with a break of day between workouts. The 40-minute workout is completed 2 times under supervision in the clinic's internal training group for outpatients. 1 time they train on their own at home, based on a defined training program. The training process is documented by the training protocol. The incipient exercise intensity is taking personal performance into account. The exercise intensity is increased by a progressive scheme. |
Total 120min exercise
|
|
Comparatore attivo: Strength exercise
Physical Therapy with a focus on stability and strength exercise. Strength exercise arm has also same duration of 12 weeks with comparable intensity. The program is according to a predetermined program. The 60-minute training is completed twice under supervision in the clinic's internal training group for outpatients.There is no contact with participants of other group. Between the two exercise sessions there is a training free day. The training process is documented by the training protocol. The incipient exercise intensity is considering personal performance. The intensity is increased after workout usual principles. The exercises are described with clear image and load parameters. The training exercises are regularly monitored. |
Total 120 min exercise
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change from Baseline in Gait variables
Lasso di tempo: Change from Baseline in Gait variables at week 3, week 7, and at the end of therapy (week 12)
|
Gait variables will be assessed with the OptoGait system OptoGait system is a floor-based photocell system for measuring spatiotemporal gait parameters. All measurements will be executed within 1hour |
Change from Baseline in Gait variables at week 3, week 7, and at the end of therapy (week 12)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Balance
Lasso di tempo: Baseline, week 3, week 7, and at the end of therapy (week 12)
|
Time to Stability (Forceplate Accusway AMTI)
|
Baseline, week 3, week 7, and at the end of therapy (week 12)
|
|
Health questionnaire
Lasso di tempo: Baseline, week 3, week 7, and at the end of therapy (week 12), followup 12 months
|
EQ-5D is a standardised instrument for use as a measure of health outcome.
|
Baseline, week 3, week 7, and at the end of therapy (week 12), followup 12 months
|
|
Foot function questionnaire
Lasso di tempo: Baseline, week 3, week 7, and at the end of therapy (week 12)
|
The Foot and Ankle Ability Measure (FAAM) is a self-report outcome instrument developed to assess physical function for individuals with foot and ankle related impairments.
|
Baseline, week 3, week 7, and at the end of therapy (week 12)
|
|
Personal calendar
Lasso di tempo: 12 months
|
Participant could enter any new ankle sprain into this calendar.
As soon as possible after new ankle sprain the participant had to fill in the date, its cause, and sprain-related injuries.
The calendar pages contained questions about the circumstances surrounding the new ankle sprain, including how and where it happened, activity performed, possible injury symptoms, time to recover and whether medical assistance or physical therapy was needed.
Participants are also requested to record direct medical costs (e.g.
physiotherapy, visits to general practitioners and medical specialists, nursing care, and medication) and indirect cost (e.g.
disability related loss) using the "personal calendar".
At the end of 2 month, a calendar page was sent by each patient to the investigators
|
12 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Jaap Swanneburg, PhD, Balgrist Univeresty Hospital
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- Balgrist 2009-124
- KEK-ZH-Nr. 2009-124 (Altro identificatore: Ethics commission of the Canton Zurich, Switzerland)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .